Pan Y, Jiao FY. Imperative for long-term management and surveillance in Kawasaki disease. World J Clin Cases 2025; 13(4): 99637 [DOI: 10.12998/wjcc.v13.i4.99637]
Corresponding Author of This Article
Fu-Yong Jiao, PhD, Senior Scientist, Shaanxi Kawasaki Disease Diagnosis and Treatment Center, Children’s Hospital, Shaanxi Provincial People’s Hospital of Xi’an Jiaotong University, No. 256 Youyi West Road, Beilin District, Xi’an 710000, Shaanxi Province, China. 3105089948@qq.com
Research Domain of This Article
Health Care Sciences & Services
Article-Type of This Article
Letter to the Editor
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Cases. Feb 6, 2025; 13(4): 99637 Published online Feb 6, 2025. doi: 10.12998/wjcc.v13.i4.99637
Imperative for long-term management and surveillance in Kawasaki disease
Yan Pan, Fu-Yong Jiao
Yan Pan, Department of Pediatrics, The First Affiliated Hospital of Yangtze University, Jingzhou 434000, Hubei Province, China
Fu-Yong Jiao, Shaanxi Kawasaki Disease Diagnosis and Treatment Center, Children’s Hospital, Shaanxi Provincial People’s Hospital of Xi’an Jiaotong University, Xi’an 710000, Shaanxi Province, China
Author contributions: Jiao FY designed the research study; Pan Y performed the research.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Fu-Yong Jiao, PhD, Senior Scientist, Shaanxi Kawasaki Disease Diagnosis and Treatment Center, Children’s Hospital, Shaanxi Provincial People’s Hospital of Xi’an Jiaotong University, No. 256 Youyi West Road, Beilin District, Xi’an 710000, Shaanxi Province, China. 3105089948@qq.com
Received: July 26, 2024 Revised: September 27, 2024 Accepted: October 29, 2024 Published online: February 6, 2025 Processing time: 111 Days and 14.4 Hours
Abstract
Kawasaki disease (KD) is a significant pediatric vasculitis known for its potential to cause severe coronary artery complications. Despite the effectiveness of initial treatments, such as intravenous immunoglobulin, KD patients can experience long-term cardiovascular issues, as evidenced by a recent case report of an adult who suffered a ST-segment elevation myocardial infarction due to previous KD in the World Journal of Clinical Cases. This editorial emphasizes the critical need for long-term management and regular surveillance to prevent such complications. By drawing on recent research and case studies, we advocate for a structured approach to follow-up care that includes routine cardiac evaluations and preventive measures.
Core Tip: Kawasaki disease management requires ongoing surveillance due to the risk of severe coronary artery complications. Consistent follow-up and preventive care are essential for reducing the risk of adverse cardiovascular events in Kawasaki disease patients.
